Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Namkyoung Kim

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|November 18, 2021
Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKsHanna Cho, Namkyoung Kim, Takashi Murakami, et al.
RSC Medicinal Chemistry|February 10, 2025
Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinomaYounghoon Kim, Jaewon Song, Namkyoung Kim, et al.
Bioscience Reports|December 13, 2018
Procaspase activating compound 1 controls tetracycline repressor-regulated gene expression systemChiman Song, Namkyoung Kim, Miri Park, et al.
Journal of Medicinal Chemistry|April 18, 2022
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug ResistanceSeongShick Ryu, Yunju Nam, Namkyoung Kim, et al.
European Journal of Medicinal Chemistry|July 21, 2023
Synthesis and antibacterial activities of baulamycin A inspired derivativesNamkyoung Kim, Sandip Sengupta, Jiwon Lee, et al.
International Journal of Molecular Sciences|April 30, 2021
Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug ResistanceNamkyoung Kim, Injae Shin, Jiwon Lee, et al.
Cancers|January 8, 2023
Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib ResistanceYunju Nam, Chan Kim, Junghee Han, et al.
Cancers|June 19, 2024
Correction: Nam et al. Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. <i>Cancers</i> 2023, <i>15</i>, 143Yunju Nam, Chan Kim, Junghee Han, et al.
European Journal of Medicinal Chemistry|July 26, 2023
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitorsNamkyoung Kim, Chan-Jung Park, Younghoon Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 30, 2023
Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug ConjugatesSooin Kim, Sanggil Kim, Sangji Kim, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|November 18, 2021
Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKsHanna Cho, Namkyoung Kim, Takashi Murakami, et al.
RSC Medicinal Chemistry|February 10, 2025
Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinomaYounghoon Kim, Jaewon Song, Namkyoung Kim, et al.
Bioscience Reports|December 13, 2018
Procaspase activating compound 1 controls tetracycline repressor-regulated gene expression systemChiman Song, Namkyoung Kim, Miri Park, et al.
Journal of Medicinal Chemistry|April 18, 2022
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug ResistanceSeongShick Ryu, Yunju Nam, Namkyoung Kim, et al.
European Journal of Medicinal Chemistry|July 21, 2023
Synthesis and antibacterial activities of baulamycin A inspired derivativesNamkyoung Kim, Sandip Sengupta, Jiwon Lee, et al.
International Journal of Molecular Sciences|April 30, 2021
Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug ResistanceNamkyoung Kim, Injae Shin, Jiwon Lee, et al.
Cancers|January 8, 2023
Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib ResistanceYunju Nam, Chan Kim, Junghee Han, et al.
Cancers|June 19, 2024
Correction: Nam et al. Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. <i>Cancers</i> 2023, <i>15</i>, 143Yunju Nam, Chan Kim, Junghee Han, et al.
European Journal of Medicinal Chemistry|July 26, 2023
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitorsNamkyoung Kim, Chan-Jung Park, Younghoon Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 30, 2023
Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug ConjugatesSooin Kim, Sanggil Kim, Sangji Kim, et al.
Pageof 2